{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T13:56:11Z","timestamp":1648821371495},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2006,12,1]],"date-time":"2006-12-01T00:00:00Z","timestamp":1164931200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2006,12]]},"DOI":"10.1007\/s00108-006-1732-6","type":"journal-article","created":{"date-parts":[[2006,10,31]],"date-time":"2006-10-31T13:29:09Z","timestamp":1162301349000},"page":"1239-1244","source":"Crossref","is-referenced-by-count":0,"title":["Therapie cholestatischer Lebererkrankungen"],"prefix":"10.1007","volume":"47","author":[{"given":"J.","family":"Pausch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Gatzen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"1732_CR1","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.jhep.2004.11.009","volume":"42","author":"Beuers","year":"2005","unstructured":"Beuers U (2005) Hepatic overlap syndromes. J Hepatol 42: 593\u2013599","journal-title":"J Hepatol"},{"key":"1732_CR2","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/hep.1840160315","volume":"16","author":"Beuers","year":"1992","unstructured":"Beuers U, Spengler U, Kruis W et al. (1992) Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: a placebo-controlled trial. Hepatology 16: 707\u2013714","journal-title":"Hepatology"},{"key":"1732_CR3","first-page":"1041","volume":"35","author":"Beuers","year":"1997","unstructured":"Beuers U, Wiedmann K, Kleber G et al. (1997) Therapie der autoimmunen Hepatitis, prim\u00e4r bili\u00e4ren Zirrhose und prim\u00e4r sklerosierenden Cholangitis. Z Gastroenterol 35: 1041\u20131049","journal-title":"Z Gastroenterol"},{"key":"1732_CR4","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1002\/hep.510230627","volume":"23","author":"Colombo","year":"1996","unstructured":"Colombo C, Battezzati PM, Podda M et al. (1996) Ursodeoxycholic acid for liver disease associated with cystic fibrosis: a double blind multicenter trial. Hepatology 23: 1484\u20131490","journal-title":"Hepatology"},{"key":"1732_CR5","first-page":"759","volume":"22","author":"Combes","year":"1995","unstructured":"Combes B, Carithers RL, Maddrey WO et al. (1995) A randomised double blind, placebo-controlled trial of ursodeoxycholic acid in primary biliary cirrhosis. Hepatology 22: 759\u2013766","journal-title":"Hepatology"},{"key":"1732_CR6","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1056\/NEJM199910283411807","volume":"341","author":"De Groen","year":"1999","unstructured":"De Groen PC, Gores GJ, La Russo NF et al. (1999) Biliary tract cancers. N Engl J Med 341: 1368\u20131378","journal-title":"N Engl J Med"},{"key":"1732_CR7","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s00063-002-1139-7","volume":"97","author":"Gatzen","year":"2002","unstructured":"Gatzen M, Pausch J (2002) Therapie cholestatischer Lebererkrankungen. Med Klin 97: 152\u2013159","journal-title":"Med Klin"},{"key":"1732_CR8","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1053\/he.2000.5984","volume":"31","author":"Heathcote","year":"2000","unstructured":"Heathcote EJ (2000) Management of primary biliary cirrhosis. The American Association for the Study of Liver diseases practice guidelines. Hepatology 31: 1005\u20131013","journal-title":"Hepatology"},{"key":"1732_CR9","first-page":"1149","volume":"19","author":"Heathcote","year":"1994","unstructured":"Heathcote JL, Cauch-Dudek K, Walker V et al. (1994) The Candadian multicenter double-blind randomised controlled trial of ursodeoxycholic acid in primary biliary cirrhosis. Gastroenterology 19: 1149\u20131156","journal-title":"Gastroenterology"},{"key":"1732_CR10","unstructured":"Holtmeier J, Leuschner U (2004) Schwangerschaftspruritus und Cholestase \u2013 was kann man tun? Gyn\u00e4kol Prax 28: 413\u2013422"},{"key":"1732_CR11","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S1089-3261(05)70139-2","volume":"4","author":"Jaquenin","year":"2000","unstructured":"Jaquenin E (2000) Progressive familial intrahepatic cholestasis. Clinics in Liver Disease 4: 753\u2013763","journal-title":"Clinics in Liver Disease"},{"key":"1732_CR12","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1056\/NEJMra043898","volume":"353","author":"Kaplan","year":"2005","unstructured":"Kaplan MM, Gershwin E (2005) Primary biliary cirrhosis. N Engl J Med 353: 1261\u20131273","journal-title":"N Engl J Med"},{"key":"1732_CR13","first-page":"961","volume":"27","author":"Keppler","year":"1999","unstructured":"Keppler D (1999) Transport of organic anions across the hepatocyte canalicular membrane. Jpn Pharmacol Ther 27: 961\u2013964","journal-title":"Jpn Pharmacol Ther"},{"key":"1732_CR14","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1055\/s-2000-9391","volume":"20","author":"Keppler","year":"2000","unstructured":"Keppler D, K\u00f6nig J (2000) Hepatic secretion of conjugated drugs and endogenous substances. Semin Liver Dis 20: 265\u2013272","journal-title":"Semin Liver Dis"},{"key":"1732_CR15","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1055\/s-2000-9390","volume":"20","author":"Lee","year":"2000","unstructured":"Lee J, Boyer JL (2000) Molecular alterations in hepatocyte transport mechanisms in acquired cholestatic liver desorders. Semin Liver Dis 20: 379\u2013384","journal-title":"Semin Liver Dis"},{"key":"1732_CR16","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/0016-5085(89)91698-3","volume":"97","author":"Leuschner","year":"1989","unstructured":"Leuschner U, Fischer H, Kurtz W et al. (1989) Ursodeoxycholic acid in primary biliary cirrhosis: results of a controlled double-blind trial. Gastroenterology 97: 1268\u20131274","journal-title":"Gastroenterology"},{"key":"1732_CR17","doi-asserted-by":"crossref","unstructured":"Leuschner U, G\u00fcld\u00fctuna S, You T et al. (1996) Ursodeoxycholic acid and prednisone versus ursodeoxycholic acid and placebo in the treatment of early stages of primary biliary cirrhosis. J Hepatol. 25: 49\u201357","DOI":"10.1016\/S0168-8278(96)80327-8"},{"key":"1732_CR18","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/S0016-5085(99)70351-3","volume":"117","author":"Leuschner","year":"1999","unstructured":"Leuschner U, Maier KP, Schlichting J et al. (1999) Oral budesonide and ursodeoxycholic acid for treatment of primary biliary cirrhosis: results of a prospective double blind trial. Gastroenterology 117: 918\u2013925","journal-title":"Gastroenterology"},{"key":"1732_CR19","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1055\/s-2005-858281","volume":"43","author":"Leuschner","year":"2005","unstructured":"Leuschner U, Manns MP, Eisebitt R (2005) Ursodeoxycholic acid in the therapy for primary biliary cirrhosis: effects on progression and prognosis. Z Gastroenterol 43: 1051\u20131059","journal-title":"Z Gastroenterol"},{"key":"1732_CR20","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1056\/NEJM199703063361003","volume":"336","author":"Lindor","year":"1997","unstructured":"Lindor KDL and the Mayo PSC\/UDCA Study Group (1997) Ursodiol for treatment of primary sclerosing cholangitis. N Engl J Med 336: 691\u2013695","journal-title":"N Engl J Med"},{"key":"1732_CR21","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1053\/gast.1996.v110.pm8613058","volume":"110","author":"Lindor","year":"1996","unstructured":"Lindor KDL, Therneau TM, Jorgensen RA et al. (1996) Effects of ursodeoxycholic acid on survival in patients with primary biliary cirrhosis. Gastroenterology 110: 1515\u20131518","journal-title":"Gastroenterology"},{"key":"1732_CR22","first-page":"Th","volume":"40","author":"Mitchell","year":"1997","unstructured":"Mitchell SA, Bansi D, Hunt N et al. (1997) High dose ursodeoxycolic acid (UDCA) in primary sclerosing cholangitis (PSC): results after two years of a randomised double-blind placebo-controlled trial. Gut 40 [Suppl 1]: Th 115","journal-title":"Gut"},{"key":"1732_CR23","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1007\/BF02779195","volume":"25","author":"Oka","year":"1980","unstructured":"Oka H, Toda Y, Ikeda Y et al. (1980) A multicenter double-blind controlled trial of ursodeoxycholic acid for primary biliary cirrhosis. Gastroenterol Jpn 25: 774\u2013780","journal-title":"Gastroenterol Jpn"},{"key":"1732_CR24","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1053\/jhep.2002.36088","volume":"36","author":"Paumgartner","year":"2002","unstructured":"Paumgartner G, Beuers U (2002) Ursodeoxycholic acid in cholestatic liver disease: mechanismus of action and therapeutic use revisited. Hepatology 36: 525\u2013531","journal-title":"Hepatology"},{"key":"1732_CR25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0163-7258(94)00073-C","volume":"60","author":"Poupon","year":"1995","unstructured":"Poupon R, Poupon RE (1995) Ursodeoxycholic acid therapy of chronic cholestatic conditions in adults and children. Pharmacol Ther 60: 1\u201315","journal-title":"Pharmacol Ther"},{"key":"1732_CR26","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1056\/NEJM199405123301903","volume":"330","author":"Poupon","year":"1994","unstructured":"Poupon RE, Poupon R, Balkau B et al. (1994) Ursodiol for the long-term treatment of primary biliary cirrhosis. N Engl J Med 330: 1342\u20131347","journal-title":"N Engl J Med"},{"key":"1732_CR27","unstructured":"Reichen J, Kr\u00e4henb\u00fchl S, Zimmermann H (1994) Impact of cholestasis on hepatic function: retention of cholephiles and their potential targets. In: Gentilini P et al. (Eds) Cholestasis. Elsevier, Amsterdam, pp 167\u2013175"},{"key":"1732_CR28","doi-asserted-by":"crossref","unstructured":"Sch\u00f6lmerich J, Baumgartner U, Miyai K et al. (1990) Tauroursodeoxycholate prevents taurolithocholate-induced cholestasis and toxicity in rat liver. J Hepatol. 10: 280\u2013283","DOI":"10.1016\/0168-8278(90)90133-C"},{"key":"1732_CR29","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1055\/s-2005-858311","volume":"43","author":"Schramm","year":"2005","unstructured":"Schramm C, Galle PR (2005) Die prim\u00e4r sklerosierende Cholangitis als Pr\u00e4kanzerose. Z Gastroenterol 43: 607\u2013611","journal-title":"Z Gastroenterol"},{"key":"1732_CR30","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/S0168-8278(97)80421-7","volume":"26","author":"Stiehl","year":"1997","unstructured":"Stiehl A, Rudolph G, Sauer P et al. (1997) Efficacy of ursodeoxycholic acid and endoscopic dilatation of major duct stenoses in primary sclerosing cholangitis: an 8-year prospective study. J Hepatol 26: 560\u2013566","journal-title":"J Hepatol"},{"key":"1732_CR31","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0168-8278(05)80467-2","volume":"20","author":"Stiehl","year":"1994","unstructured":"Stiehl A, Walker S, Stiehl L (1994) Effects of ursodeoxycholic acid on liver and bile duct disease in primary sclerosing cholangitis. A 3-year pilot study with a placebo-controlled study period. J Hepatol 20: 57\u201364","journal-title":"J Hepatol"},{"key":"1732_CR32","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0140-6736(03)13808-1","volume":"362","author":"Talwalkar","year":"2003","unstructured":"Talwalkar JA, Lindor D (2003) Primary biliary cirrhosis. Lancet 362: 53\u201361","journal-title":"Lancet"},{"key":"1732_CR33","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1024\/0040-5930.61.8.521","volume":"61","author":"Thimme","year":"2004","unstructured":"Thimme R, Opitz OG, Blum HE et al. (2004) Cholestatische Hepatopathien. Therapeutische Umschau 61: 521\u2013527","journal-title":"Therapeutische Umschau"},{"key":"1732_CR34","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/00001574-200305000-00005","volume":"19","author":"Trauner","year":"2003","unstructured":"Trauner M, Boyer JL (2003) Cholestatic syndromes. Curr Opin Gastroenterol 19: 216\u2013231","journal-title":"Curr Opin Gastroenterol"},{"key":"1732_CR35","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1440-1746.1994.tb01237.x","volume":"9","author":"Turner","year":"1994","unstructured":"Turner JB, Myszor M, Mitchison HC et al. (1994) A two year controlled trial examining the effectiveness of ursodeoxycholic acid in primary biliary cirrhosis. J Gastroenterol Hepatol 9: 162\u2013168","journal-title":"J Gastroenterol Hepatol"},{"key":"1732_CR36","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/S0140-6736(87)91208-6","volume":"2","author":"Ullrich","year":"1987","unstructured":"Ullrich D, Rating D, Schr\u00f6ter W et al. (1987) Treatment with ursodeoxycholic acid renders children with biliary atresia suitable for liver transplantation. Lancet 2: 1324","journal-title":"Lancet"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-006-1732-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00108-006-1732-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-006-1732-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T04:11:38Z","timestamp":1558584698000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00108-006-1732-6"}},"subtitle":["Mehr als Substitution fettl\u00f6slicher Vitamine?"],"short-title":[],"issued":{"date-parts":[[2006,12]]},"references-count":36,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["1732"],"URL":"https:\/\/doi.org\/10.1007\/s00108-006-1732-6","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,12]]}}}